日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

新合成的噻唑衍生物作为抗白色念珠菌的潜在抗真菌化合物

Anna Biernasiuk, Anna Berecka-Rycerz, Anna Gumieniczek, Maria Malm, Krzysztof Z Łączkowski, Jolanta Szymańska, Anna Malm

Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer

EBV 相关口咽癌的血清和组织 TLR9 水平

Ewa Stępień, Małgorzata Strycharz-Dudziak, Maria Malm, Bartłomiej Drop, Małgorzata Polz-Dacewicz

Placental transporter-mediated drug interactions and offspring congenital anomalies

胎盘转运蛋白介导的药物相互作用与后代先天性异常

Ellfolk, Maria; Tornio, Aleksi; Niemi, Mikko; Leinonen, Maarit K; Lahesmaa-Korpinen, Anna-Maria; Malm, Heli

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana

轮状病毒 VP6 作为本氏烟生产的二价诺如病毒疫苗的佐剂

Maria Malm, André Diessner, Kirsi Tamminen, Markus Liebscher, Timo Vesikari, Vesna Blazevic

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant

祖先和最新大流行诺如病毒 GII.4 变体的免疫交叉反应

Kirsi Tamminen, Maria Malm, Timo Vesikari, Vesna Blazevic

Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization

与序贯免疫相比,同时使用多价诺如病毒 VLP 进行免疫可诱导更好的针对诺如病毒的保护性免疫反应

Maria Malm, Timo Vesikari, Vesna Blazevic

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

轮状病毒重组 VP6 纳米管可作为诺如病毒病毒样颗粒的免疫调节剂和运载载体

Maria Malm, Kirsi Tamminen, Suvi Lappalainen, Timo Vesikari, Vesna Blazevic

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

轮状病毒衣壳 VP6 蛋白在联合疫苗中作为诺如病毒样颗粒的体内佐剂

Vesna Blazevic, Maria Malm, Daisuke Arinobu, Suvi Lappalainen, Timo Vesikari

Multiple consecutive norovirus infections in the first 2 years of life

出生后 2 年内多次连续感染诺如病毒

Vesna Blazevic, Maria Malm, Marjo Salminen, Sami Oikarinen, Heikki Hyöty, Riitta Veijola, Timo Vesikari